Duality Advisers, LP Insmed Inc Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$20.88 - $28.21 $1.51 Million - $2.04 Million
72,364 New
72,364 $1.56 Million
Q2 2022

Aug 08, 2022
SELL
$17.07 - $25.71 $151,940 - $228,844
-8,901 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$20.42 - $28.13 $181,758 - $250,385
8,901 New
8,901 $209,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email